<span>ICH Q14 101: Applying AQbD to CMC for Regulatory Success</span>
September 27, 2023

ICH Q14 101: Applying AQbD to CMC for Regulatory Success

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q14 is a new quality document describing analytical procedure development. Previously, no ICH guidance specifically covered analytical method development, resulting in a lack of clarity on what to present to regulators.

<span>Labcorp Biopharmaceutical CMC Analytical Development Services</span>
September 27, 2023

Labcorp Biopharmaceutical CMC Analytical Development Services

The underlying principle for biopharmaceutical development and manufacturing is to provide a drug product that is both safe and efficacious for the patient. Therefore, manufacturing of any drug substance and drug product must demonstrate consistent production of a quality product, which must be shown to be stable over its intended shelf life.